Psyence Biomedical Ltd.
PBM
$3.48
-$0.08-2.25%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.47M | -2.47M | -996.40K | -996.40K | -974.40K |
| Total Depreciation and Amortization | 1.30K | 1.30K | 1.30K | 1.30K | 1.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 125.30K | 125.30K | -123.20K | -123.20K | 150.10K |
| Change in Net Operating Assets | -711.70K | -711.70K | 103.60K | 103.60K | -286.10K |
| Cash from Operations | -3.06M | -3.06M | -1.01M | -1.01M | -1.11M |
| Capital Expenditure | 0.00 | 0.00 | -100.00 | -100.00 | -1.70K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -250.00K | -250.00K | -2.01M | -2.01M | -3.20K |
| Cash from Investing | -250.00K | -250.00K | -2.01M | -2.01M | -4.90K |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | 871.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 3.45M | 3.45M | 3.53M | 3.53M | 2.34M |
| Cash from Financing | 3.45M | 3.45M | 3.53M | 3.53M | 3.22M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 147.40K | 147.40K | 507.40K | 507.40K | 2.10M |